Montagu Private Equity

2 More London Riverside
London, SE1 2AP

Website: montagu.com

Firm Size

  • Assets Under Management (AUM):$7.5 Billion
  • Number of Funds:13
  • Employees:
  • Firm Type:Private Equity
  • Focus Areas: Services
    Healthcare
    Consumer


Description

Montagu Private Equity, LLP is a private equity firm based in London, United Kingdom. The company specializes in investing in middle-market companies across various sectors, including industrial, healthcare, consumer, and business services. Montagu focuses on partnering with management teams to support growth and value creation through operational improvements, strategic acquisitions, and international expansion. With over 50 years of experience, Montagu has built a strong track record of successful investments and has completed over 250 transactions. The firm has a team of experienced professionals with deep industry knowledge and expertise in executing complex transactions. Montagu typically invests in companies with enterprise values ranging from €100 million to €1 billion, utilizing a flexible approach that includes majority or minority equity investments, as well as leveraged buyouts. The firm values long-term relationships and aims to be a trusted partner for its portfolio companies, offering strategic guidance and operational support to drive sustainable growth. As an established player in the European private equity market, Montagu has developed a substantial network of contacts and relationships, providing access to valuable resources and deal flow. The firm is committed to responsible investing and adheres to high ethical standards. Overall, Montagu Private Equity, LLP is a reputable firm with a successful history of investing in middle-market companies and driving value creation through strategic initiatives.

Latest News

Powered by

Mar 20, 2024: Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis.